Reduced vision in a diabetic patient due to incidental leukaemic retinopathy

Clin Exp Optom. 2019 Jan;102(1):91-93. doi: 10.1111/cxo.12808. Epub 2018 Jul 10.
No abstract available

Keywords: anti-vascular endothelial growth factor; chronic myeloid; leukaemia; leukostasis retinopathy; macular oedema.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetic Retinopathy / diagnosis*
  • Humans
  • Incidental Findings
  • Intravitreal Injections
  • Laser Coagulation
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Macular Edema / diagnosis
  • Macular Edema / drug therapy
  • Male
  • Middle Aged
  • Receptors, Vascular Endothelial Growth Factor / therapeutic use
  • Recombinant Fusion Proteins / therapeutic use
  • Retinal Neoplasms / diagnosis*
  • Retinal Neoplasms / drug therapy
  • Retinal Neovascularization / diagnosis
  • Retinal Neovascularization / drug therapy
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vision, Low / diagnosis*
  • Visual Acuity / physiology

Substances

  • Angiogenesis Inhibitors
  • Recombinant Fusion Proteins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • aflibercept
  • Receptors, Vascular Endothelial Growth Factor